Form 4: Amgen Director Brian Druker Acquires 665 Shares

Amgen Inc. Director Brian Druker acquired 665 shares of common stock through the immediate vesting of Restricted Stock Units.

Summary

• Director Brian Druker acquired 665 shares of Amgen Inc. common stock on May 19, 2026.
• The acquisition resulted from the immediate vesting of Restricted Stock Units (RSUs) granted under the company's 2009 Director Incentive Program.
• Following this transaction, the reporting person holds a total of 8,391 shares of common stock.
• The transaction was executed at a price of $0 per share as part of director compensation.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a standard regulatory disclosure regarding director compensation and does not signal a change in company strategy or financial health.

Positives

• Increased equity alignment between the director and shareholders.
• Standard director compensation practice indicating continued board participation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that this filing represents routine director compensation within the biotechnology sector, reflecting standard corporate governance practices for board members.

Comparison to Industry Standards

• The use of RSUs for director compensation is a standard practice among large-cap pharmaceutical and biotechnology companies.
• The immediate vesting and one-to-one conversion ratio align with typical equity incentive plans for board directors at companies like Amgen.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity grant to a director.

Next Steps

• None mentioned.

Key Dates

Keywords

Amgen, AMGN, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan